-
1 Comment
Luyan Pharma Co.,Ltd is currently in a long term downtrend where the price is trading 8.0% below its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Luyan Pharma Co.,Ltd's total revenue rose by 5.9% to $4B since the same quarter in the previous year.
Its net income has increased by 10.1% to $83M since the same quarter in the previous year.
Finally, its free cash flow fell by 134.1% to $-264M since the same quarter in the previous year.
Based on the above factors, Luyan Pharma Co.,Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| ISIN | CNE1000025W1 |
| Market Cap | 3B |
|---|---|
| Dividend Yield | 3.6% |
| Beta | 0.48 |
| PE Ratio | 9.45 |
| Target Price | None |
Luyan Pharma Co.,Ltd. distributes and sells medicines, Chinese herbal medicines, medical devices, and vaccines in China. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 2008 and is headquartered in Xiamen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002788.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
